trending Market Intelligence /marketintelligence/en/news-insights/trending/qrychj7javo2_l86ojlcgg2 content esgSubNav
In This List

Evolent Health issues Q2 guidance

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Blog

Kensho Launches Word Error Rate Calculator

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

Blog

Bank failures: The importance of liquidity and funding data


Evolent Health issues Q2 guidance

Evolent Health issued guidance for the second quarter and reaffirmed its outlook for full year 2018.

For the second quarter, the company expects adjusted revenue of about $139.0 million to $143.0 million, and adjusted EBITDA of approximately $3.0 million to $5.0 million.

For the first quarter, Evolent Health reported a net loss attributable to the company of $13.6 million, or 18 cents per share, compared to a net loss of $18.0 million, or 34 cents per share, in the year-ago period.

For full year 2018, the company continues to expect adjusted revenue of approximately $565.0 million to $585.0 million, and adjusted EBITDA of about $18.0 million to $23.0 million.